April W. Armstrong, MD, MPH
Disclosures: Consultant/Advisor-Abbvie|Research Support-Abbvie|Research Support-Bristol-Myers Squibb|Consultant/Advisor-Bristol-Myers Squibb|Consultant/Advisor-Dermavant|Research Support-Dermira|Consultant/Advisor-Eli Lilly and Company|Research Support-Eli Lilly and Company|Consultant/Advisor-Janssen|Research Support-Janssen|Research Support-Kyowa Hakko Kirin|Consultant/Advisor-Leo Pharma|Research Support-Leo Pharma|Consultant/Advisor-Modernizing Medicine|Consultant/Advisor-Novartis AG|Research Support-Novartis AG|Consultant/Advisor-Ortho Dermatologics|Consultant/Advisor-Pfizer, Inc.|Consultant/Advisor-Regeneron|Research Support-Regeneron|Consultant/Advisor-Sanofi Genzyme|Research Support-Sanofi Genzyme|Consultant/Advisor-Science 37|Consultant/Advisor-Sun Pharma|Consultant/Advisor-UCB Biopharma










Dr. April Armstrong is Associate Dean at Keck School of Medicine of the University of Southern California (USC). She also serves as Director of Clinical Research Support at the Southern California Clinical and Translational Science Institute (CTSI). Dr. Armstrong also serves as Vice Chair and Director of Psoriasis Program in the dermatology department at USC. Dr. Armstrong obtained her MD and completed dermatology residency at Harvard. She also obtained a MPH in Clinical Effectiveness from Harvard School of Public Health.

Dr. Armstrong is highly committed to clinical research and the care of patients with inflammatory skin diseases such as psoriasis and atopic dermatitis. Her research in focuses on (1) investigating comorbidities related to psoriasis and atopic dermatitis, (2) identifying treatment patterns, treatment goals, and economic burden of inflammatory skin disease, and (3) increasing patient access using innovative, technology-enabled healthcare delivery methods. She has conducted over 100 clinical trials and published over 210 articles in scientific journals. She holds multiple leadership positions at professional societies, including the National Psoriasis Foundation, Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), the International Psoriasis Council, and the American Academy of Dermatology. She is an associate Editor for JAMA Dermatology and has also served on the editorial boards of JAAD and Telemedicine and eHealth.